BME100 s2014:W Group9 L2

BME 100 Fall 2013	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Kyndal Sorenson Name: Kayla Cummins Name: Maryam Ibrahim Name: Mohammad Mousa Name: Quintin Woods LAB 2 WRITE-UP Descriptive Statistics Experiment 1 Standard Deviation Average Count Standard Error 0mg 1.523010177 3.834 10 0.481618106 5mg 1.593931547 8.932 10 0.504045412 10mg 30.11069386 61.622 10 9.521837451 15mg 212.9429762 657.941 10 67.33848166 Experiment 2 Standard Deviation Average Count Standard Error 0mg 2.225551617 10.516 5 0.995296941 10mg 7.402885924 11.112 5 3.310671231 Results Experiment 1 ‎Experiment 2 Analysis Experiment 1 Experiment 2 Summary/Discussion After calculating the descriptive statistics and inferential statistics, group 9 was able to determine appropriate P-Values for the data from the human and rodent experiments. The ANOVA test conducted on the human data gave a value of less than 0.05. This indicates that there is a significant difference in Inflammotin levels according to LPS dosage levels. The graph showed a significant jump in Inflammotin levels from subjects who received 10mg of LPS and subjects who received 15mg. The graph also showed the standard deviation increased with the dosage amount. That indicated that the drug can have a varying affect in subjects. For the rodent subjects, the ANOVA test showed no significant difference in Inflammotin levels with LPS dosage because the P-value exceeded 0.05.